TrialResults-center.org
Search
Menu
Home
Search
Recent trials
Browse pathology
Browse treatment
About us
Brigatinib
ALK inhibitors
Description
Results
brigatinib - AP26113
Group by
Group by...
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
in first
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
in second
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
in third
All pathologies
Toggle Dropdown
All pathologies
lung cancer (metastatic)
Question
ALK positive patients
669 - 246
Patients
death (overall survival)
progression or death (progression free survival PFS)
pdf
pathology
Benefit (demonstrated or suggested) and harm
×
Modal title